CORD-19:c654596857bce9cdd64ffc51842048643107348c / 185201-185289 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/c654596857bce9cdd64ffc51842048643107348c","sourcedb":"CORD-19","sourceid":"c654596857bce9cdd64ffc51842048643107348c","text":"Production of IFNa increased after using viferon (recombinant a2b IFN and antioxidants).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1551","span":{"begin":0,"end":88},"obj":"Sentence"},{"id":"T15387","span":{"begin":0,"end":88},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1551","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T15387","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T298","span":{"begin":0,"end":88},"obj":"Sentence"}],"attributes":[{"subj":"T298","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a0ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93ba"}]}]}}